316 related articles for article (PubMed ID: 30214007)
21. Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1.
Takacova M; Holotnakova T; Barathova M; Pastorekova S; Kopacek J; Pastorek J
Oncol Rep; 2010 Mar; 23(3):869-74. PubMed ID: 20127031
[TBL] [Abstract][Full Text] [Related]
22. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
23. Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer.
Singh-Gupta V; Joiner MC; Runyan L; Yunker CK; Sarkar FH; Miller S; Gadgeel SM; Konski AA; Hillman GG
J Thorac Oncol; 2011 Apr; 6(4):688-98. PubMed ID: 21325978
[TBL] [Abstract][Full Text] [Related]
24. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
[TBL] [Abstract][Full Text] [Related]
25. A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer.
Kato A; Ng S; Thangasamy A; Han H; Zhou W; Raeppel S; Fallon M; Guha S; Ammanamanchi S
Mol Carcinog; 2021 Nov; 60(11):734-745. PubMed ID: 34347914
[TBL] [Abstract][Full Text] [Related]
26. CA9 and PRELID2; hypoxia-responsive potential therapeutic targets for pancreatic ductal adenocarcinoma as per bioinformatics analyses.
Imanishi M; Inoue T; Fukushima K; Yamashita R; Nakayama R; Nojima M; Kondo K; Gomi Y; Tsunematsu H; Goto K; Miyamoto L; Funamoto M; Denda M; Ishizawa K; Otaka A; Fujino H; Ikeda Y; Tsuchiya K
J Pharmacol Sci; 2023 Dec; 153(4):232-242. PubMed ID: 37973221
[TBL] [Abstract][Full Text] [Related]
27. IGFL2-AS1-induced suppression of HIF-1α degradation promotes cell proliferation and invasion in colorectal cancer by upregulating CA9.
Qin M; Liu Q; Yang W; Wang Q; Xiang Z
Cancer Med; 2023 Apr; 12(7):8415-8432. PubMed ID: 36537608
[TBL] [Abstract][Full Text] [Related]
28. Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.
Mijit M; Liu S; Sishtla K; Hartman GD; Wan J; Corson TW; Kelley MR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674619
[TBL] [Abstract][Full Text] [Related]
29. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.
Zou GM; Karikari C; Kabe Y; Handa H; Anders RA; Maitra A
J Cell Physiol; 2009 Apr; 219(1):209-18. PubMed ID: 19097035
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
Chen S; Xiong G; Wu S; Mo J
Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
[TBL] [Abstract][Full Text] [Related]
31. Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia.
Ihnatko R; Kubes M; Takacova M; Sedlakova O; Sedlak J; Pastorek J; Kopacek J; Pastorekova S
Int J Oncol; 2006 Oct; 29(4):1025-33. PubMed ID: 16964400
[TBL] [Abstract][Full Text] [Related]
32. HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression.
Kessler J; Hahnel A; Wichmann H; Rot S; Kappler M; Bache M; Vordermark D
BMC Cancer; 2010 Nov; 10():605. PubMed ID: 21050481
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptors 2, 4 and 9 and hypoxia markers HIF-1alpha and CAIX in pancreatic intraepithelial neoplasia.
Leppänen J; Helminen O; Huhta H; Kauppila JH; Isohookana J; Haapasaari KM; Karihtala P; Parkkila S; Saarnio J; Lehenkari PP; Karttunen TJ
APMIS; 2018 Nov; 126(11):852-863. PubMed ID: 30357962
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the redox function of APE1/Ref-1 in myeloid leukemia cell lines results in a hypersensitive response to retinoic acid-induced differentiation and apoptosis.
Fishel ML; Colvin ES; Luo M; Kelley MR; Robertson KA
Exp Hematol; 2010 Dec; 38(12):1178-88. PubMed ID: 20826193
[TBL] [Abstract][Full Text] [Related]
35. Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas.
Couvelard A; O'Toole D; Leek R; Turley H; Sauvanet A; Degott C; Ruszniewski P; Belghiti J; Harris AL; Gatter K; Pezzella F
Histopathology; 2005 Jun; 46(6):668-76. PubMed ID: 15910598
[TBL] [Abstract][Full Text] [Related]
36. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
[TBL] [Abstract][Full Text] [Related]
37. HIF-1 attenuates Ref-1 expression in endothelial cells: reversal by siRNA and inhibition of geranylgeranylation.
Loboda A; Stachurska A; Dorosz J; Zurawski M; Wegrzyn J; Kozakowska M; Jozkowicz A; Dulak J
Vascul Pharmacol; 2009; 51(2-3):133-9. PubMed ID: 19524065
[TBL] [Abstract][Full Text] [Related]
38. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
39. Extracellularly secreted APE1/Ref-1 triggers apoptosis in triple-negative breast cancer cells via RAGE binding, which is mediated through acetylation.
Lee YR; Kim KM; Jeon BH; Choi S
Oncotarget; 2015 Sep; 6(27):23383-98. PubMed ID: 26125438
[TBL] [Abstract][Full Text] [Related]
40. Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia.
Ding J; Fishel ML; Reed AM; McAdams E; Czader MB; Cardoso AA; Kelley MR
Mol Cancer Ther; 2017 Jul; 16(7):1401-1411. PubMed ID: 28446640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
